Grouping of PFAS for human health risk assessment

Ideally, PFAS groupings should be based only on common toxic MOAs and/or target organs. Only those PFAS that affect the same target organ/tissue/system should ...

Grouping of PFAS for human health risk assessment - PubMed

An expert panel was convened to provide insight and guidance on per- and polyfluoroalkyl substances (PFAS) grouping for the purposes of ...

Our Current Understanding of the Human Health and Environmental ...

What EPA is Doing · Per- and Polyfluoroalkyl Substances (PFAS) Are a Group of Manufactured Chemicals · PFAS Can Be Found in Many Places · People ...

Grouping of Per- and Polyfluoroalkyl Substances (PFAS) for Human ...

How should PFAS be defined for human health risk assessment purposes (e.g., ... be grouped for human health risk assessment purposes, (e.g. for derivation ...

Grouping of PFAS for human health risk assessment - ResearchGate

Most experts agreed that “all PFAS” should not be grouped together, persistence alone is not sufficient for grouping PFAS for the purposes of ...

Strategies for grouping per- and polyfluoroalkyl substances (PFAS ...

The least precautionary grouping approach reviewed advocates only grouping PFAS for risk assessment that have the same toxicological effects, modes and ...

7 Human and Ecological Health Effects of select PFAS

Section 7.1 provides information on human biomonitoring and exposure, toxicokinetics, toxicology in mammalian species, and human epidemiology for long-chain and ...

Application of a Framework for Grouping and Mixtures Toxicity ...

This article presents a new and systematic analysis of available PFAS toxicity study data using a tiered mixtures risk assessment framework.

[PDF] Grouping of PFAS for human health risk assessment

Semantic Scholar extracted view of "Grouping of PFAS for human health risk assessment: Findings from an independent panel of experts.

Learn about the Human Health Toxicity Assessment for PFBS

Perfluorobutane sulfonic acid (PFBS) is a member of a larger group of per- and polyfluoroalkyl substances (PFAS). The toxicity assessment is a written summary ...

Human and Ecological Health Effects and Risk Assessment of Per

Since their identification as contaminants of emerging concern in the early. 2000s, per- and polyfluoroalkyl substances (PFAS) have been the focus of.

Risks of PFAS for human health in Europe (Signal)

... group , to limit human exposure to other PFAS ... risk assessment', International Journal of Hygiene and Environmental Health 230, p.

Assessing Human Health Risks from Per- and Polyfluoroalkyl ...

The relative source contribution specifies the proportion of the total daily exposure attributed to dietary uptake of PFAS-contaminated ...

Independent Expert Panel Provides Insights on Grouping of PFAS ...

Independent Expert Panel Provides Insights on Grouping of PFAS for Human Health Risk Assessment ... To group or not to group, that is the question ...

An integrated assessment of ecological and human health risks of per

Per- and polyfluoroalkyl substances (PFAS) are also known as “forever chemicals” due to their persistence and ubiquitous environmental ...

How to group PFAS? Expert panel finds no single answer

The panelists agreed that “human health risk assessment must be based on the principles of hazard and exposure” and that “compound-specific mode ...

What are PFAS and how are they dangerous for my health?

Comprising more than 4 700 chemicals, perfluorinated and polyfluorinated alkyl substances (PFAS) are a group of widely used, man-made ...

Strategies for grouping per- and polyfluoroalkyl substances (PFAS ...

The least precautionary grouping approach reviewed advocates only grouping PFAS for risk assessment that have the same toxicological effects, ...

Per- and Polyfluoroalkyl Substances (PFAS) - FDA

Per- and polyfluoroalkyl substances (PFAS) are a diverse group of thousands of chemicals used in hundreds of types of products.

Grouping of PFAS for human health risk assessment - OUCI

Grouping of PFAS for human health risk assessment: Findings from an independent panel of experts ; Journal: Regulatory Toxicology and Pharmacology, 2022, p.